Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT01093092. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT01167816. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma
ClinicalTrials.gov study NCT00744640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT02358161. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium
ClinicalTrials.gov study NCT01090466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
ClinicalTrials.gov study NCT03609216. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT06390059. IPD Sharing: NO. Countries: 4. Publications: 0.
A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen
ClinicalTrials.gov study NCT05138159. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
ClinicalTrials.gov study NCT06498648. IPD Sharing: YES. Countries: 1. Publications: 0.
Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT05671900. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas
ClinicalTrials.gov study NCT02739633. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine for Marginal Zone Lymphoma
ClinicalTrials.gov study NCT00337259. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT01764477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides
ClinicalTrials.gov study NCT03789864. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvent Dose-dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT07184021. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients
ClinicalTrials.gov study NCT02245217. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT05669482. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine
ClinicalTrials.gov study NCT00937664. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 3b, Open-label, Multi-center Study on Durvalumab in Combination With Gemcitabine-based Chemotherapy as 1L Treatment for the Chinese Patients With Unresectable Biliary Tract Cancers (BTC)
ClinicalTrials.gov study NCT05924880. IPD Sharing: YES. Countries: 1. Publications: 0.
Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin
ClinicalTrials.gov study NCT00055965. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.